Compositions comprising magnolia, phellodendron, theanine and/or whey protein

1. An anxiolytic composition, comprising a combination of L-theanine, a whey protein, an extract of magnolia , and an extract of phellodendron provided in amounts synergistically effective to modulate one or more neurotransmitters.

2. The anxiolytic composition of claim 1 , wherein the whey protein comprises alpha-lactalbumin.

3. The anxiolytic composition of claim 1 , wherein the combination provides an anxiolytic change in a release pattern of one or more neurotransmitters.

4. The anxiolytic composition of claim 3 , wherein the neurotransmitters are brain neurotransmitters selected from the group consisting of γ-aminobutyric acid (GABA) and serotonin.

5. The anxiolytic composition of claim 1 , formulated for oral administration to a mammal.

6. The anxiolytic composition of claim 5 , wherein the mammal is selected from the group consisting of a human, a companion animal, and an equine animal.

7. A method for reducing, ameliorating, or treating symptoms of anxiety, comprising administration to a mammal of a combination of L-theanine, a whey protein, an extract of magnolia , and an extract of phellodendron in amounts synergistically effective to modulate one or more neurotransmitters.

8. The method of claim 7 , further including providing the whey protein as a whey protein concentrate comprising alpha-lactalbumin.

9. The method of claim 7 , including orally administering the combination in an amount sufficient to provide an anxiolytic change in a release pattern of the one or more neurotransmitters.

10. The method of claim 9 , wherein the neurotransmitters are brain neurotransmitters selected from the group consisting of γ-aminobutyric acid (GABA) and serotonin.

11. The method of claim 7 , wherein the mammal is a canine or feline.

12. The method of claim 7 , wherein the mammal is an equine.